Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dysregulation of miR‐543 in Parkinson's disease: Impact on the neuroprotective gene SIRT1

10 Nov 2022

Abstract excerpt

AIMS: Parkinson's disease (PD) is a progressive and age-dependent neurodegenerative disease characterised clinically by a variety of motor symptoms and cognitive impairment. PD was initially considered to be a grey matter disease; however, recently, evidence has emerged that white matter changes in PD precede the neuronal loss seen in the grey matter. The cause of these initial white matter changes is yet to be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments
Share to Sirtuins and Resveratrol in Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36352829
DOI: 10.1111/nan.12864

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dysregulation of miR‐543 in Parkinson's disease: Impact on the neuroprotective gene SIRT1PMID 36352829Read ↗

miR-486-3p Influences the Neurotoxicity of a-Synuclein by Targeting the SIRT2 Gene and the Polymorphisms at Target Sites Contributing to Parkinson’s DiseaseSemantic proximity Read ↗

Regulatory miRNA–mRNA Networks in Parkinson’s DiseaseSemantic proximity Read ↗

ROLE OF MICRORNAS IN THE PATHOGENESIS OF PARKINSON'S DISEASESemantic proximity Read ↗

MicroRNA-4639 Is a Regulator of DJ-1 Expression and a Potential Early Diagnostic Marker for Parkinson’s DiseaseSemantic proximity Read ↗

Meta-analyses identify differentially expressed microRNAs in Parkinson’s diseaseSemantic proximity Read ↗

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial functionSemantic proximity Read ↗

Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s DiseaseSemantic proximity Read ↗

Emerging Role of Sirtuin 2 in Parkinson’s DiseaseSemantic proximity Read ↗

Sirtuins as modifiers of Parkinson's disease pathologySemantic proximity Read ↗

Validation of Differentially Expressed Brain-Enriched microRNAs in the Plasma of Parkinson’s Disease PatientsSemantic proximity Read ↗

Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapySemantic proximity Read ↗

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.